August 10, 2022: Even as the world continues to tackle Covid-19 infections and is getting alarmed about the monkeypox outbreak, a new type of animal-derived virus has been reported in China. The Henipavirus - also known as ‘Langya’ henipavirus (LayV) - has so far infected 35 people in eastern China's Henan and Shandong provinces, the country's official media reported on Tuesday.
The Langya virus was found in the throat samples from febrile patients in the aforementioned provinces.
The virus hails from a family of viruses known to kill up to three quarters of human beings in case of severe infection. However, none of the fresh cases have so far resulted in fatality and most are mild, with patients suffering from flu-like symptoms.
At present, no vaccine or treatment for Langya virus is available, and the only solution is supportive care to manage complications pertaining to the zoonotic disease.
STORY HIGHLIGHTS
Even as the world continues to tackle COVID-19 infections and is getting alarmed about the monkeypox outbreak, a new type of animal-derived virus has been reported in China
August 10, 2022: Even as the world continues to tackle Covid-19 infections and is getting alarmed about the monkeypox outbreak, a new type of animal-derived virus has been reported in China. The Henipavirus - also known as ‘Langya’ henipavirus (LayV) - has so far infected 35 people in eastern China's Henan and Shandong provinces, the country's official media reported on Tuesday.
The Langya virus was found in the throat samples from febrile patients in the aforementioned provinces.
The virus hails from a family of viruses known to kill up to three quarters of human beings in case of severe infection. However, none of the fresh cases have so far resulted in fatality and most are mild, with patients suffering from flu-like symptoms.
At present, no vaccine or treatment for Langya virus is available, and the only solution is supportive care to manage complications pertaining to the zoonotic disease.